| Authors: |
Hart EE; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, USA; National Institute of General Medical Sciences, 45 Center Drive, Bethesda, MD 20892, USA., Gardner MPH; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, USA; Department of Psychology, Concordia University, 7141 Sherbrooke West, Montreal, QC H4B 1R6, Canada., Panayi MC; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, USA., Kahnt T; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, USA., Schoenbaum G; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, USA; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, 110 S Paca Street, Baltimore, MD 21201, USA; Department of Neuroscience, Johns Hopkins School of Medicine, 251 Bayview Boulevard, Baltimore, MD 21224, USA; Department of Psychiatry, University of Maryland School of Medicine, 110 S Paca Street, Baltimore, MD 21201, USA. Electronic address: geoffrey.schoenbaum@nih.gov. |
